ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,738.17
      -0.13%
      US Tech 100
      19,436.00
      -0.73%
      Dow Jones
      42,313.00
      0.33%
      Brent Oil
      72.01
      0.00%
      Bitcoin
      65,645.41
      -0.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MoonLake Immunotherapeutics (MLTX)

      7. MoonLake Immunotherapeutics (MLTX) News

      MoonLake Immunotherapeutics

      MoonLake Immunotherapeutics (MLTX)

      NASDAQ
      49.40
      -1.97
      (-3.83%)
      Closed September 28 4:00PM
      Delayed by 15 minutes
      49.40
      -0.02
      (-0.04%)
      After Hours: 4:20PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      MLTX News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      September 11 2024
      MLTX (-3.83%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 07 2024
      MLTX (-3.83%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 07 2024
      MLTX (-3.83%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 10 2024
      MLTX (-3.83%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      MLTX (-3.83%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      MLTX (-3.83%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      MLTX (-3.83%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      MLTX (-3.83%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 06 2024
      MLTX (-3.83%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 07 2024
      MLTX (-3.83%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 07 2024
      MLTX (-3.83%)

      MLTX Discussion

      View Posts
      Monksdream Monksdream 2 weeks ago
      MLTX in an up trend
      👍️0
      AKATITUS AKATITUS 1 year ago
      Sleeping
      Come on 70.00
      👍️0
      Monksdream Monksdream 1 year ago
      MLTX new 52 week high
      👍️0
      AKATITUS AKATITUS 1 year ago
      Haha. Now that's funny. 18,000 share buy at 52.00 dollars.
      👍️0
      AKATITUS AKATITUS 1 year ago
      Damm some big buys at 54.00 WoW
      👍️0
      AKATITUS AKATITUS 1 year ago
      Hope it busts soon.
      👍️0
      AKATITUS AKATITUS 1 year ago
      Looks like a good churning. Will tomorrow be the same. ??????
      👍️0
      MiamiGent MiamiGent 1 year ago
      MLTX Started the day with a bang. Falling back, presently

      MOONLAKE IMMUNOTHERAPEUTICS
      $41.80 +15.92 (+61.51%)
      As of Jun-26-202310:46:16 AM ET

      https://stockcharts.com/h-sc/ui?s=MLTX

      Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
      BENZINGA
      31 mins ago
      U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today's session.

      MoonLake Immunotherapeutics (NASDAQ:MLTX) jumped 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.

      (con't)
      👍️0
      AKATITUS AKATITUS 1 year ago
      So pissed I was trying to sell somethings to buy 40ts them boom 100 bucks F##########
      👍️0
      Awl416 Awl416 1 year ago
      Crazy
      👍️0
      crudeoil24 crudeoil24 2 years ago
      MoonLake Immunotherapeutics (NASDAQ: MLTX) 10% owner Bihua Chen acquired a total of 5,635,000 shares at an average price of $10.00. To acquire these shares, it cost around $28.5 million.
      👍️0

      Your Recent History

      NASDAQ
      MLTX
      MoonLake Immunotherapeut...
      Delayed Upgrade Clock